Sartorius Stedim stock: results on October 22 ahead of Xetra open
Published on 10/19/2026 at 07:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSResults date and business model
- Sartorius Stedim Biotech has scheduled its 9M 2026 results conference call for October 22, 2026.
- Repeat business with sterile single-use products accounts for approximately 80 percent of sales revenue.
- Sartorius Stedim stock trades pre-market at EUR 214.30 at 7:40 a.m. CEST at Lang & Schwarz on October 19, 2026.
Sartorius Stedim Biotech has scheduled its conference call for the 9M 2026 results for October 22, 2026, at 1 p.m. CEST, according to the company’s investor-relations page. Sartorius Stedim stock is at EUR 214.30 pre-market at Lang & Schwarz at 7:40 a.m. CEST on October 19, 2026.
The next company date
The October 22 conference call is the next scheduled company event listed by Sartorius Stedim Biotech. The investor-relations page identifies the event as the 9M 2026 results conference call and gives a start time of 1 p.m. CEST. The page also identifies Sartorius Stedim Biotech S.A. as listed on Euronext Paris.
Pre-market indication
The Lang & Schwarz indication was recorded at 7:40 a.m. CEST on October 19, 2026. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Sartorius Stedim stock.
How the company earns revenue
Sartorius Stedim Biotech supplies solutions used by biopharmaceutical companies to develop and manufacture medicines, including sterile single-use products and bioprocess technologies, according to its investor-relations page. The company says repeat business with sterile single-use products accounts for approximately 80 percent of sales revenue. Market context: Market report CAC 40.
